MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has announced its participation in the prestigious Alzheimer’s Association ...

Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering ...

OncoZenge AB (publ) (”OncoZenge” or “the Company”) announces that the Company’s board member and Chief Medical Officer Dr. Chris Nowak, will present the study design for the planned registrational ...

Asian Hospital and Medical Center (AHMC) marked a significant milestone on June 5, 2025, with the official launch of the Asian Learning Institute (ALI)—one of the hospital’s five strategic goals for ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key findings from the Phase III trial of Sodium Dichloroacetate (DCA) for Pyruvate ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“ Cybin ” or the “ Company ”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by ...

HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

NICE, France—As world leaders prepare to attend the third U.N. Ocean Conference here next week, scientists are urging them to take action to combat a dual climate and biodiversity crisis ...